Gangliosides as Therapeutic Targets for Neurodegenerative Diseases

Gangliosides, sialic acid-containing glycosphingolipids, are abundant in cell membranes and primarily involved in controlling cell signaling and cell communication. The altered ganglioside pattern has been demonstrated in several neurodegenerative diseases, characterized during early-onset or infanc...

Full description

Bibliographic Details
Main Authors: Orhan Kerim Inci, Hande Basırlı, Melike Can, Selman Yanbul, Volkan Seyrantepe
Format: Article
Language:English
Published: Hindawi Limited 2024-01-01
Series:Journal of Lipids
Online Access:http://dx.doi.org/10.1155/2024/4530255
_version_ 1797206036543700992
author Orhan Kerim Inci
Hande Basırlı
Melike Can
Selman Yanbul
Volkan Seyrantepe
author_facet Orhan Kerim Inci
Hande Basırlı
Melike Can
Selman Yanbul
Volkan Seyrantepe
author_sort Orhan Kerim Inci
collection DOAJ
description Gangliosides, sialic acid-containing glycosphingolipids, are abundant in cell membranes and primarily involved in controlling cell signaling and cell communication. The altered ganglioside pattern has been demonstrated in several neurodegenerative diseases, characterized during early-onset or infancy, emphasizing the significance of gangliosides in the brain. Enzymes required for the biosynthesis of gangliosides are linked to several devastating neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP). In this review, we summarized not only the critical roles of biosynthetic enzymes and their inhibitors in ganglioside metabolism but also the efficacy of treatment strategies of ganglioside to address their significance in those diseases.
first_indexed 2024-04-24T09:00:38Z
format Article
id doaj.art-521329955f6e49de90efdf0d3bec2409
institution Directory Open Access Journal
issn 2090-3049
language English
last_indexed 2024-04-24T09:00:38Z
publishDate 2024-01-01
publisher Hindawi Limited
record_format Article
series Journal of Lipids
spelling doaj.art-521329955f6e49de90efdf0d3bec24092024-04-16T00:00:03ZengHindawi LimitedJournal of Lipids2090-30492024-01-01202410.1155/2024/4530255Gangliosides as Therapeutic Targets for Neurodegenerative DiseasesOrhan Kerim Inci0Hande Basırlı1Melike Can2Selman Yanbul3Volkan Seyrantepe4Department of Molecular Biology and GeneticsDepartment of Molecular Biology and GeneticsDepartment of Molecular Biology and GeneticsDepartment of Molecular Biology and GeneticsDepartment of Molecular Biology and GeneticsGangliosides, sialic acid-containing glycosphingolipids, are abundant in cell membranes and primarily involved in controlling cell signaling and cell communication. The altered ganglioside pattern has been demonstrated in several neurodegenerative diseases, characterized during early-onset or infancy, emphasizing the significance of gangliosides in the brain. Enzymes required for the biosynthesis of gangliosides are linked to several devastating neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), Huntington’s disease (HD), amyotrophic lateral sclerosis (ALS), hereditary spastic paraplegia (HSP). In this review, we summarized not only the critical roles of biosynthetic enzymes and their inhibitors in ganglioside metabolism but also the efficacy of treatment strategies of ganglioside to address their significance in those diseases.http://dx.doi.org/10.1155/2024/4530255
spellingShingle Orhan Kerim Inci
Hande Basırlı
Melike Can
Selman Yanbul
Volkan Seyrantepe
Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
Journal of Lipids
title Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
title_full Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
title_fullStr Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
title_full_unstemmed Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
title_short Gangliosides as Therapeutic Targets for Neurodegenerative Diseases
title_sort gangliosides as therapeutic targets for neurodegenerative diseases
url http://dx.doi.org/10.1155/2024/4530255
work_keys_str_mv AT orhankeriminci gangliosidesastherapeutictargetsforneurodegenerativediseases
AT handebasırlı gangliosidesastherapeutictargetsforneurodegenerativediseases
AT melikecan gangliosidesastherapeutictargetsforneurodegenerativediseases
AT selmanyanbul gangliosidesastherapeutictargetsforneurodegenerativediseases
AT volkanseyrantepe gangliosidesastherapeutictargetsforneurodegenerativediseases